Short description
Lucentix develops a biosensor technology that enables patients to measure concentrations of analytes in a single drop of blood or saliva.
Description
Lucentix develops a biosensor technology that enables patients to measure concentrations of analytes in a single drop of blood or saliva by using a low-cost handheld device giving laboratory-quality results. The company's biosensors are based on the invention of a new type of biochemical sensing molecule. A light-producing enzyme called luciferase, is engineered to change the color of the emitted light in response to changes in analyte concentration. In absence of the analyte the molecular system emits red light, while at high analyte concentration the light is blue.
Lucentix is headquartered in Lausanne, Switzerland.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Lausanne, Vaud, Switzerland, Europe
Founded on
January 1, 2015
Non-profit?
No
Acquired?
No
Investors
Noaccessforu
Sign in for full access
Founders
Rudolf Griss